Approach to Managing Anemia
All patients with anemia should receive appropriate diagnostic evaluation to identify the underlying cause, followed by targeted treatment with iron supplementation as first-line therapy for iron deficiency anemia, continuing for three months after correction of anemia to replenish iron stores. 1
Diagnostic Evaluation
Initial Assessment
- Complete blood count with red cell indices
- Ferritin level (< 15 μg/dL indicates iron deficiency)
- MCV (< 76 fl suggests microcytic anemia)
- Transferrin saturation (< 20% indicates iron deficiency)
Targeted Investigation Based on Suspected Etiology
For patients > 45 years with iron deficiency anemia (IDA):
- Upper GI endoscopy with small bowel biopsies
- Lower GI examination (colonoscopy or barium enema)
- Rule out occult malignancy, celiac disease, and other GI sources of blood loss 1
For patients < 45 years:
- If upper GI symptoms: endoscopy with small bowel biopsy
- Test for celiac disease (antiendomysial antibodies and IgA levels)
- Colonic investigation only if specific indications 1
For pre-menopausal women:
- Assess menstrual blood loss (accounts for 5-10% of IDA in this population)
- Consider pictorial blood loss assessment charts (80% sensitivity/specificity) 1
Treatment Approach
Iron Deficiency Anemia
Oral Iron Therapy (First-Line):
- Ferrous sulfate 200 mg three times daily (most cost-effective option)
- Alternatives: ferrous gluconate or ferrous fumarate at equivalent doses
- Consider liquid preparations if tablets not tolerated
- Add ascorbic acid to enhance iron absorption if response is poor 1, 2
- Monitor for expected hemoglobin rise of 2 g/dL after 3-4 weeks 1
Parenteral Iron (Reserved for specific situations):
- Indications: intolerance to at least two oral preparations, non-compliance
- Disadvantages: painful administration (IM), expensive, risk of anaphylactic reactions
- Note: Rise in hemoglobin is no faster than with oral preparations 1
Duration of Therapy:
- Continue iron supplementation for three months after correction of anemia to replenish iron stores 1
Follow-up Monitoring
- Monitor hemoglobin and red cell indices every three months for one year, then after another year
- Provide additional iron if hemoglobin or MCV falls below normal
- Consider further investigation only if hemoglobin and MCV cannot be maintained 1
Special Populations
Chronic Kidney Disease
- Evaluate iron status before and during treatment
- Maintain iron repletion while using erythropoiesis-stimulating agents (ESAs) if needed
- Target hemoglobin should not exceed 11 g/dL due to increased cardiovascular risks 3, 4
Vitamin B12 Deficiency
- For pernicious anemia: intramuscular cyanocobalamin 100 mcg daily for 6-7 days, then alternate days for 7 doses, then every 3-4 weeks, followed by 100 mcg monthly for life
- Administer folic acid concomitantly if needed 5
Common Pitfalls and Caveats
Failure to identify underlying cause:
- Treating symptoms without addressing the source of blood loss or malabsorption leads to recurrence
- Up to 10-15% of patients have dual pathology (lesions in both upper and lower GI tracts) 1
Inadequate follow-up:
- Patients not responding to iron therapy should be reassessed for:
- Poor compliance
- Misdiagnosis
- Continued blood loss
- Malabsorption 1
- Patients not responding to iron therapy should be reassessed for:
Inappropriate parenteral iron use:
- Should be reserved for specific indications, not routine use
- Does not provide faster hemoglobin correction than oral therapy 1
Co-morbidity considerations:
- Carefully assess the appropriateness of invasive investigations in patients with severe co-morbidities
- Discuss risks and benefits with patients and caregivers 1
Overlooking non-GI causes:
By following this structured approach to diagnosis and management, most patients with anemia can achieve resolution within six months, with appropriate iron repletion and correction of the underlying cause.